Loading…

Absorption of a hypotonic oral rehydration solution in a human model of cholera

The development of oral rehydration solutions (ORSs) has been one of the important therapeutic advances of this century. The optimal formulation, however, of ORSs for both cholera and other infective diarrhoeas is still debated. Part of the problem in developing ORSs has been the lack of adequate te...

Full description

Saved in:
Bibliographic Details
Published in:Gut 1994-02, Vol.35 (2), p.211-214
Main Authors: Hunt, J B, Thillainayagam, A V, Carnaby, S, Fairclough, P D, Clark, M L, Farthing, M J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b506t-8557e02233dce5188efb0a114ee24448c7e96ae79fbc356f0baae3b1fd155fa93
cites cdi_FETCH-LOGICAL-b506t-8557e02233dce5188efb0a114ee24448c7e96ae79fbc356f0baae3b1fd155fa93
container_end_page 214
container_issue 2
container_start_page 211
container_title Gut
container_volume 35
creator Hunt, J B
Thillainayagam, A V
Carnaby, S
Fairclough, P D
Clark, M L
Farthing, M J
description The development of oral rehydration solutions (ORSs) has been one of the important therapeutic advances of this century. The optimal formulation, however, of ORSs for both cholera and other infective diarrhoeas is still debated. Part of the problem in developing ORSs has been the lack of adequate test systems for the assessment of new formulations before clinical trial. We have developed a jejunal perfusion, cholera toxin induced, secretory model in humans and have compared net water and solute absorption from a hypotonic ORS (HYPO-ORS: sodium 60 mmol/l, glucose 90 mmol/l, osmolality 240 mOsm/kg) and the British Pharmacopoeia recommended ORS (UK-ORS: sodium 35 mmol/l, glucose 200 mmol/l, osmolality 310 mOsm/kg) in six healthy volunteers. A plasma electrolyte solution (PES) was also perfused in all subjects to confirm a secretory state. Only HYPO-ORS reversed sodium secretion to absorption (p < 0.01). Both ORSs promoted net water absorption but this was greatest with HYPO-ORS (p < 0.01). Glucose and potassium absorption rates were similar for both ORSs whereas chloride absorption mirrored sodium absorption and was greatest from HYPO-ORS (p < 0.05). These results, in a biologically relevant model of secretory diarrhoea, suggest it may be possible to achieve improved rates of rehydration by the use of hypotonic ORS with mid range sodium concentrations.
doi_str_mv 10.1136/gut.35.2.211
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1374495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3970001871</sourcerecordid><originalsourceid>FETCH-LOGICAL-b506t-8557e02233dce5188efb0a114ee24448c7e96ae79fbc356f0baae3b1fd155fa93</originalsourceid><addsrcrecordid>eNp9kc1r3DAQxUVpSDdJb70WDA3kEm80lmTJl0Cy5AtCA_noVYy9UtZb29pIdsj-99Fml6W59KSB95s3jydCfgAdA7D85Hnox0yMs3EG8IWMgOcqZZlSX8mIUpCpkLz4RvZCmFNKlSpgl-wqRiWXMCJ3Z2VwftHXrkucTTCZLReud11dJc5jk3gzW049fujBNcPHUHcrcGixS1o3Nc1qs5q5xng8IDsWm2C-b9598nR58Ti5Tm_vrm4mZ7dpKWjep0oIaWiWMTatjACljC0pAnBjMs65qqQpcjSysGXFRG5piWhYCXYKQlgs2D45XfsuhrI10aTrY1y98HWLfqkd1vqz0tUz_exeNTDJeSGiwa-NgXcvgwm9nrvBdzGzBikpzaEAGqnjNVV5F4I3dnsBqF61r2P7mgmd6dh-xH_-m2oLb-qO-uFGx1BhYz12VR22GCuEit8XsXSN1aE3b1sZ_V-dSyaF_v1notkDiBz4vT6P_NGaL9v5_wO-A6t9qeE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770061910</pqid></control><display><type>article</type><title>Absorption of a hypotonic oral rehydration solution in a human model of cholera</title><source>PubMed (Medline)</source><creator>Hunt, J B ; Thillainayagam, A V ; Carnaby, S ; Fairclough, P D ; Clark, M L ; Farthing, M J</creator><creatorcontrib>Hunt, J B ; Thillainayagam, A V ; Carnaby, S ; Fairclough, P D ; Clark, M L ; Farthing, M J</creatorcontrib><description>The development of oral rehydration solutions (ORSs) has been one of the important therapeutic advances of this century. The optimal formulation, however, of ORSs for both cholera and other infective diarrhoeas is still debated. Part of the problem in developing ORSs has been the lack of adequate test systems for the assessment of new formulations before clinical trial. We have developed a jejunal perfusion, cholera toxin induced, secretory model in humans and have compared net water and solute absorption from a hypotonic ORS (HYPO-ORS: sodium 60 mmol/l, glucose 90 mmol/l, osmolality 240 mOsm/kg) and the British Pharmacopoeia recommended ORS (UK-ORS: sodium 35 mmol/l, glucose 200 mmol/l, osmolality 310 mOsm/kg) in six healthy volunteers. A plasma electrolyte solution (PES) was also perfused in all subjects to confirm a secretory state. Only HYPO-ORS reversed sodium secretion to absorption (p &lt; 0.01). Both ORSs promoted net water absorption but this was greatest with HYPO-ORS (p &lt; 0.01). Glucose and potassium absorption rates were similar for both ORSs whereas chloride absorption mirrored sodium absorption and was greatest from HYPO-ORS (p &lt; 0.05). These results, in a biologically relevant model of secretory diarrhoea, suggest it may be possible to achieve improved rates of rehydration by the use of hypotonic ORS with mid range sodium concentrations.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>EISSN: 1458-3288</identifier><identifier>DOI: 10.1136/gut.35.2.211</identifier><identifier>PMID: 8307471</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Adult ; Bacterial diseases ; Biological and medical sciences ; Chlorides - metabolism ; Cholera ; Cholera - metabolism ; Cholera Toxin - administration &amp; dosage ; Fluid Therapy ; Glucose - metabolism ; Human bacterial diseases ; Humans ; Infectious diseases ; Intestinal Absorption - physiology ; Jejunum - metabolism ; Male ; Medical sciences ; Models, Biological ; Osmolar Concentration ; Perfusion ; Potassium - metabolism ; Rehydration Solutions - metabolism ; Sodium - metabolism ; Tropical bacterial diseases ; Water - metabolism</subject><ispartof>Gut, 1994-02, Vol.35 (2), p.211-214</ispartof><rights>1994 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Feb 1994</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b506t-8557e02233dce5188efb0a114ee24448c7e96ae79fbc356f0baae3b1fd155fa93</citedby><cites>FETCH-LOGICAL-b506t-8557e02233dce5188efb0a114ee24448c7e96ae79fbc356f0baae3b1fd155fa93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1374495/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1374495/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3958146$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8307471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hunt, J B</creatorcontrib><creatorcontrib>Thillainayagam, A V</creatorcontrib><creatorcontrib>Carnaby, S</creatorcontrib><creatorcontrib>Fairclough, P D</creatorcontrib><creatorcontrib>Clark, M L</creatorcontrib><creatorcontrib>Farthing, M J</creatorcontrib><title>Absorption of a hypotonic oral rehydration solution in a human model of cholera</title><title>Gut</title><addtitle>Gut</addtitle><description>The development of oral rehydration solutions (ORSs) has been one of the important therapeutic advances of this century. The optimal formulation, however, of ORSs for both cholera and other infective diarrhoeas is still debated. Part of the problem in developing ORSs has been the lack of adequate test systems for the assessment of new formulations before clinical trial. We have developed a jejunal perfusion, cholera toxin induced, secretory model in humans and have compared net water and solute absorption from a hypotonic ORS (HYPO-ORS: sodium 60 mmol/l, glucose 90 mmol/l, osmolality 240 mOsm/kg) and the British Pharmacopoeia recommended ORS (UK-ORS: sodium 35 mmol/l, glucose 200 mmol/l, osmolality 310 mOsm/kg) in six healthy volunteers. A plasma electrolyte solution (PES) was also perfused in all subjects to confirm a secretory state. Only HYPO-ORS reversed sodium secretion to absorption (p &lt; 0.01). Both ORSs promoted net water absorption but this was greatest with HYPO-ORS (p &lt; 0.01). Glucose and potassium absorption rates were similar for both ORSs whereas chloride absorption mirrored sodium absorption and was greatest from HYPO-ORS (p &lt; 0.05). These results, in a biologically relevant model of secretory diarrhoea, suggest it may be possible to achieve improved rates of rehydration by the use of hypotonic ORS with mid range sodium concentrations.</description><subject>Adult</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Chlorides - metabolism</subject><subject>Cholera</subject><subject>Cholera - metabolism</subject><subject>Cholera Toxin - administration &amp; dosage</subject><subject>Fluid Therapy</subject><subject>Glucose - metabolism</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Intestinal Absorption - physiology</subject><subject>Jejunum - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Models, Biological</subject><subject>Osmolar Concentration</subject><subject>Perfusion</subject><subject>Potassium - metabolism</subject><subject>Rehydration Solutions - metabolism</subject><subject>Sodium - metabolism</subject><subject>Tropical bacterial diseases</subject><subject>Water - metabolism</subject><issn>0017-5749</issn><issn>1468-3288</issn><issn>1458-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNp9kc1r3DAQxUVpSDdJb70WDA3kEm80lmTJl0Cy5AtCA_noVYy9UtZb29pIdsj-99Fml6W59KSB95s3jydCfgAdA7D85Hnox0yMs3EG8IWMgOcqZZlSX8mIUpCpkLz4RvZCmFNKlSpgl-wqRiWXMCJ3Z2VwftHXrkucTTCZLReud11dJc5jk3gzW049fujBNcPHUHcrcGixS1o3Nc1qs5q5xng8IDsWm2C-b9598nR58Ti5Tm_vrm4mZ7dpKWjep0oIaWiWMTatjACljC0pAnBjMs65qqQpcjSysGXFRG5piWhYCXYKQlgs2D45XfsuhrI10aTrY1y98HWLfqkd1vqz0tUz_exeNTDJeSGiwa-NgXcvgwm9nrvBdzGzBikpzaEAGqnjNVV5F4I3dnsBqF61r2P7mgmd6dh-xH_-m2oLb-qO-uFGx1BhYz12VR22GCuEit8XsXSN1aE3b1sZ_V-dSyaF_v1notkDiBz4vT6P_NGaL9v5_wO-A6t9qeE</recordid><startdate>19940201</startdate><enddate>19940201</enddate><creator>Hunt, J B</creator><creator>Thillainayagam, A V</creator><creator>Carnaby, S</creator><creator>Fairclough, P D</creator><creator>Clark, M L</creator><creator>Farthing, M J</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>19940201</creationdate><title>Absorption of a hypotonic oral rehydration solution in a human model of cholera</title><author>Hunt, J B ; Thillainayagam, A V ; Carnaby, S ; Fairclough, P D ; Clark, M L ; Farthing, M J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b506t-8557e02233dce5188efb0a114ee24448c7e96ae79fbc356f0baae3b1fd155fa93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Chlorides - metabolism</topic><topic>Cholera</topic><topic>Cholera - metabolism</topic><topic>Cholera Toxin - administration &amp; dosage</topic><topic>Fluid Therapy</topic><topic>Glucose - metabolism</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Intestinal Absorption - physiology</topic><topic>Jejunum - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Models, Biological</topic><topic>Osmolar Concentration</topic><topic>Perfusion</topic><topic>Potassium - metabolism</topic><topic>Rehydration Solutions - metabolism</topic><topic>Sodium - metabolism</topic><topic>Tropical bacterial diseases</topic><topic>Water - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hunt, J B</creatorcontrib><creatorcontrib>Thillainayagam, A V</creatorcontrib><creatorcontrib>Carnaby, S</creatorcontrib><creatorcontrib>Fairclough, P D</creatorcontrib><creatorcontrib>Clark, M L</creatorcontrib><creatorcontrib>Farthing, M J</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hunt, J B</au><au>Thillainayagam, A V</au><au>Carnaby, S</au><au>Fairclough, P D</au><au>Clark, M L</au><au>Farthing, M J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Absorption of a hypotonic oral rehydration solution in a human model of cholera</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>1994-02-01</date><risdate>1994</risdate><volume>35</volume><issue>2</issue><spage>211</spage><epage>214</epage><pages>211-214</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><eissn>1458-3288</eissn><coden>GUTTAK</coden><abstract>The development of oral rehydration solutions (ORSs) has been one of the important therapeutic advances of this century. The optimal formulation, however, of ORSs for both cholera and other infective diarrhoeas is still debated. Part of the problem in developing ORSs has been the lack of adequate test systems for the assessment of new formulations before clinical trial. We have developed a jejunal perfusion, cholera toxin induced, secretory model in humans and have compared net water and solute absorption from a hypotonic ORS (HYPO-ORS: sodium 60 mmol/l, glucose 90 mmol/l, osmolality 240 mOsm/kg) and the British Pharmacopoeia recommended ORS (UK-ORS: sodium 35 mmol/l, glucose 200 mmol/l, osmolality 310 mOsm/kg) in six healthy volunteers. A plasma electrolyte solution (PES) was also perfused in all subjects to confirm a secretory state. Only HYPO-ORS reversed sodium secretion to absorption (p &lt; 0.01). Both ORSs promoted net water absorption but this was greatest with HYPO-ORS (p &lt; 0.01). Glucose and potassium absorption rates were similar for both ORSs whereas chloride absorption mirrored sodium absorption and was greatest from HYPO-ORS (p &lt; 0.05). These results, in a biologically relevant model of secretory diarrhoea, suggest it may be possible to achieve improved rates of rehydration by the use of hypotonic ORS with mid range sodium concentrations.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>8307471</pmid><doi>10.1136/gut.35.2.211</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 1994-02, Vol.35 (2), p.211-214
issn 0017-5749
1468-3288
1458-3288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1374495
source PubMed (Medline)
subjects Adult
Bacterial diseases
Biological and medical sciences
Chlorides - metabolism
Cholera
Cholera - metabolism
Cholera Toxin - administration & dosage
Fluid Therapy
Glucose - metabolism
Human bacterial diseases
Humans
Infectious diseases
Intestinal Absorption - physiology
Jejunum - metabolism
Male
Medical sciences
Models, Biological
Osmolar Concentration
Perfusion
Potassium - metabolism
Rehydration Solutions - metabolism
Sodium - metabolism
Tropical bacterial diseases
Water - metabolism
title Absorption of a hypotonic oral rehydration solution in a human model of cholera
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T02%3A33%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Absorption%20of%20a%20hypotonic%20oral%20rehydration%20solution%20in%20a%20human%20model%20of%20cholera&rft.jtitle=Gut&rft.au=Hunt,%20J%20B&rft.date=1994-02-01&rft.volume=35&rft.issue=2&rft.spage=211&rft.epage=214&rft.pages=211-214&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.35.2.211&rft_dat=%3Cproquest_pubme%3E3970001871%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b506t-8557e02233dce5188efb0a114ee24448c7e96ae79fbc356f0baae3b1fd155fa93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1770061910&rft_id=info:pmid/8307471&rfr_iscdi=true